Manzi reflected on progress in the lupus field and more research to be done with anifrolumab and beyond.
Allegheny Health Network
Latest Content
Manzi discussed shifting goals to remission in the lupus field.
Manzi discussed findings from the phase 3 TULIP-SC trial of subcutaneous anifrolumab for systemic lupus erythematosus.
Although the benefits of telehealth are clear, it is not without its challenges. As the field of rheumatology moves into a post-pandemic world, the future of telemedicine hangs in the balance.
Advertisement
Advertisement
Trending on Rheumatology Live
1
Retatrutide Cuts Knee OA Pain, With Philip Conaghan, MBBS, PhD
2
Bimekizumab Leads New Wave of PsA Comparative Data: Philip Mease, MD
3
CD19 CAR T Shows Early Remission in Treatment-Refractory RA
4
Adding Tirzepatide Improves PsA Control in Obesity: Philip Mease, MD
5